ATE162397T1 - Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren - Google Patents

Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren

Info

Publication number
ATE162397T1
ATE162397T1 AT94909762T AT94909762T ATE162397T1 AT E162397 T1 ATE162397 T1 AT E162397T1 AT 94909762 T AT94909762 T AT 94909762T AT 94909762 T AT94909762 T AT 94909762T AT E162397 T1 ATE162397 T1 AT E162397T1
Authority
AT
Austria
Prior art keywords
microparticles
composition
compressed phase
disclosed
phase
Prior art date
Application number
AT94909762T
Other languages
English (en)
Inventor
Julio M Fernandez
Mark B Knudson
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE162397T1 publication Critical patent/ATE162397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94909762T 1993-02-12 1994-02-10 Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren ATE162397T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1768193A 1993-02-12 1993-02-12

Publications (1)

Publication Number Publication Date
ATE162397T1 true ATE162397T1 (de) 1998-02-15

Family

ID=21783984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909762T ATE162397T1 (de) 1993-02-12 1994-02-10 Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren

Country Status (9)

Country Link
EP (1) EP0684812B1 (de)
JP (1) JPH08509956A (de)
AT (1) ATE162397T1 (de)
AU (1) AU676543B2 (de)
CA (1) CA2155648C (de)
DE (1) DE69408122T2 (de)
DK (1) DK0684812T3 (de)
ES (1) ES2114184T3 (de)
WO (1) WO1994017786A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
GB9320668D0 (en) 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
JPH11505505A (ja) 1994-06-27 1999-05-21 ザ・ジョンズ・ホプキンス・ユニバーシティー ターゲッティングされた遺伝子輸送システム
JP2000514440A (ja) * 1996-07-09 2000-10-31 ザ ジョーンズ ホプキンス ユニバーシティー 遺伝子輸送システム
ES2317657T3 (es) * 1996-09-19 2009-04-16 The Regents Of The University Of Michigan Polimeros que contienen polisacaridos tales como alginatos o alginatos modificados.
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US5952232A (en) * 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
DE19943429A1 (de) * 1999-09-08 2001-03-15 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an sulfonierten Kammpolymeren
US8246945B2 (en) 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
AU1951001A (en) 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US20030138975A1 (en) * 2001-12-20 2003-07-24 Kimberly-Clark Worldwide, Inc. Diagnostic signal amplification with proteinoid microspheres
US7056535B2 (en) 2001-12-20 2006-06-06 Kimberly-Clark Worldwide, Inc. Triggered release from proteinoid microspheres

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI84874C (fi) * 1989-11-02 1992-02-10 Valio Meijerien Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den.
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
FR2677249B1 (fr) * 1991-06-04 1995-03-17 Biovecteurs As Vecteur particulaire biodegradable et procede de synthese.

Also Published As

Publication number Publication date
DE69408122T2 (de) 1998-09-03
CA2155648A1 (en) 1994-08-18
DK0684812T3 (da) 1998-09-21
CA2155648C (en) 1999-05-11
ES2114184T3 (es) 1998-05-16
AU6247994A (en) 1994-08-29
AU676543B2 (en) 1997-03-13
JPH08509956A (ja) 1996-10-22
EP0684812B1 (de) 1998-01-21
EP0684812A1 (de) 1995-12-06
WO1994017786A1 (en) 1994-08-18
DE69408122D1 (de) 1998-02-26

Similar Documents

Publication Publication Date Title
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
ATE162397T1 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
AU6819294A (en) Oral drug delivery compositions and methods
EP1015008A4 (de) Verbindungen und zusammensetzungen zur administration aktiver stoffe
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
DE69433723D1 (de) Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
DK1137400T3 (da) Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode
ATE363899T1 (de) Pharmazeutische zusammensetzungen mit modafinil
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE302210T1 (de) Histogranin peptide und deren analgetische verwendung
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
HUP0300221A3 (en) Use of oltipraz as an antifibrotic and anticirrhotic agent in the liver for producing pharmaceutical compositions and pharmaceutical compositions containing oltipraz and process for producing them
HRP20000781B1 (hr) Šumeći pripravci
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
DE69827650D1 (de) Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung
IL109730A0 (en) Methods for administering biological agents and microparticle compositions useful in these and other methods
DK8291D0 (da) Praeparat omfattende en aktiv bestanddel, fortrinsvis i pulver- eller partikelform, samt en baerer for den aktive bestanddel og fremgangsmaade til fremstilling af et saadant praeparat
ZA943551B (en) Methods for administering biological agents and microparticle compositions useful in these and other methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee